A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

Clinical trial NCT07001475 · COMPLETED

Trial details

NCT number: NCT07001475
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Borderline Personality Disorder Attention Deficit Hyperactivity Disorder

Start date: 2025-08-12
Primary completion: 2026-08-06
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.